{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:44:57Z","timestamp":1791474297467,"version":"4.3.4"},"reference-count":139,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1097\/hco.0000000000000331","type":"journal-article","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T23:05:13Z","timestamp":1472684713000},"page":"635-643","source":"Crossref","is-referenced-by-count":34,"title":["Secondary prevention after coronary artery bypass graft surgery"],"prefix":"10.1097","volume":"31","author":[{"given":"Alexander","family":"Kulik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210204","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/00325481.1953.11711334","article-title":"The physician's role in preventive medicine and public health","volume":"13","author":"Leavell","year":"1953","journal-title":"Postgrad Med"},{"key":"R2-10-20210204","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1037\/0003-066X.41.4.453","article-title":"Primary prevention. Historical perspectives and a blueprint for action","volume":"41","author":"Goldston","year":"1986","journal-title":"Am Psychol"},{"key":"R3-10-20210204","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0140-6736(95)90119-1","article-title":"Preventive healthcare","volume":"345","author":"Patterson","year":"1995","journal-title":"Lancet"},{"key":"R4-10-20210204","first-page":"e28","article-title":"Heart disease and stroke statistics: 2014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"R5-10-20210204","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/CIR.0000000000000182","article-title":"Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association","volume":"131","author":"Kulik","year":"2015","journal-title":"Circulation"},{"key":"R6-10-20210204","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.CIR.87.2.659","article-title":"Aspirin as a therapeutic agent in cardiovascular disease. Special writing group","volume":"87","author":"Fuster","year":"1993","journal-title":"Circulation"},{"key":"R7-10-20210204","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"R8-10-20210204","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1517\/14740330902797081","article-title":"Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy","volume":"8","author":"Kulik","year":"2009","journal-title":"Expert Opin Drug Saf"},{"key":"R9-10-20210204","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIR.0b013e318256f1e0","article-title":"2012 ACCF\/AHA focused update of the guideline for the management of patients with unstable angina\/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"126","author":"Jneid","year":"2012","journal-title":"Circulation"},{"key":"R10-10-20210204","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1161\/CIR.0b013e3182742c84","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"127","author":"O\u2019Gara","year":"2013","journal-title":"Circulation"},{"key":"R11-10-20210204","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1056\/NEJMoa1507688","article-title":"Stopping vs. continuing aspirin before coronary artery surgery","volume":"374","author":"Myles","year":"2016","journal-title":"N Engl J Med"},{"key":"R12-10-20210204","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/S0003-4975(00)02133-0","article-title":"Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients","volume":"70","author":"Dacey","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"R13-10-20210204","doi-asserted-by":"crossref","first-page":"I286","DOI":"10.1161\/CIRCULATIONAHA.104.522805","article-title":"Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting","volume":"112","author":"Bybee","year":"2005","journal-title":"Circulation"},{"key":"R14-10-20210204","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa020798","article-title":"Aspirin and mortality from coronary bypass surgery","volume":"347","author":"Mangano","year":"2002","journal-title":"N Engl J Med"},{"key":"R15-10-20210204","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0002-8703(92)90496-I","article-title":"Aspirin use and survival after coronary bypass surgery","volume":"123","author":"Johnson","year":"1992","journal-title":"Am Heart J"},{"key":"R16-10-20210204","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1093\/eurheartj\/ehs367","article-title":"Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial","volume":"33","author":"Farooq","year":"2012","journal-title":"Eur Heart J"},{"key":"R17-10-20210204","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM198207083070201","article-title":"A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency","volume":"307","author":"Chesebro","year":"1982","journal-title":"N Engl J Med"},{"key":"R18-10-20210204","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM198401263100401","article-title":"Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations","volume":"310","author":"Chesebro","year":"1984","journal-title":"N Engl J Med"},{"key":"R19-10-20210204","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1161\/01.CIR.77.6.1324","article-title":"Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study","volume":"77","author":"Goldman","year":"1988","journal-title":"Circulation"},{"key":"R20-10-20210204","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1161\/01.CIR.80.5.1190","article-title":"Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study","volume":"80","author":"Goldman","year":"1989","journal-title":"Circulation"},{"key":"R21-10-20210204","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/1010-7940(93)90155-5","article-title":"Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis","volume":"7","author":"Fremes","year":"1993","journal-title":"Eur J Cardiothorac Surg"},{"key":"R22-10-20210204","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1001\/jama.294.19.2446","article-title":"Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial","volume":"294","author":"Alexander","year":"2005","journal-title":"JAMA"},{"key":"R23-10-20210204","first-page":"221","article-title":"Individual variation in the effects of ASA on platelet function: Implications for the use of ASA clinically","volume":"11","author":"Buchanan","year":"1995","journal-title":"Can J Cardiol"},{"key":"R24-10-20210204","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1067\/mtc.2001.111416","article-title":"Aspirin resistance after coronary artery bypass grafting","volume":"121","author":"Zimmermann","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R25-10-20210204","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.thromres.2004.07.004","article-title":"Late saphenous vein graft occlusion in patients with coronary bypass: possible role of aspirin resistance","volume":"115","author":"Yilmaz","year":"2005","journal-title":"Thromb Res"},{"key":"R26-10-20210204","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1053\/j.jvca.2011.12.004","article-title":"Evaluation of aspirin's effect on platelet function early after coronary artery bypass grafting","volume":"26","author":"Bednar","year":"2012","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R27-10-20210204","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/35051599","article-title":"Identification of the platelet ADP receptor targeted by antithrombotic drugs","volume":"409","author":"Hollopeter","year":"2001","journal-title":"Nature"},{"key":"R28-10-20210204","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1161\/01.CIR.100.15.1667","article-title":"Ticlopidine and clopidogrel","volume":"100","author":"Quinn","year":"1999","journal-title":"Circulation"},{"key":"R29-10-20210204","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1161\/01.CIR.101.24.2823","article-title":"Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans","volume":"101","author":"Cadroy","year":"2000","journal-title":"Circulation"},{"key":"R30-10-20210204","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"R31-10-20210204","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"R32-10-20210204","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jtcvs.2009.07.027","article-title":"Aspirin and clopidogrel use in the early postoperative period following on-pump and off-pump coronary artery bypass grafting","volume":"138","author":"Kim","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R33-10-20210204","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jacc.2010.09.069","article-title":"Efficacy of postoperative clopidogrel treatment in patients revascularized with coronary artery bypass grafting after myocardial infarction","volume":"57","author":"Sorensen","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R34-10-20210204","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.athoracsur.2013.08.058","article-title":"Effect of clopidogrel use post coronary artery bypass surgery on graft patency","volume":"97","author":"Ebrahimi","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"R35-10-20210204","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.athoracsur.2009.04.024","article-title":"Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting","volume":"88","author":"Gao","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"R36-10-20210204","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1161\/CIRCULATIONAHA.110.978007","article-title":"Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: The clopidogrel after surgery for coronary artery disease (CASCADE) trial","volume":"122","author":"Kulik","year":"2010","journal-title":"Circulation"},{"key":"R37-10-20210204","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.ahj.2010.07.035","article-title":"Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the preoperative aspirin and postoperative antiplatelets in coronary artery bypass grafting study","volume":"160","author":"Sun","year":"2010","journal-title":"Am Heart J"},{"key":"R38-10-20210204","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jacc.2010.03.104","article-title":"Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial","volume":"56","author":"Gao","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R39-10-20210204","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1136\/heartjnl-2012-302449","article-title":"Aspirin plus clopidogrel for optimal platelet inhibition following off-pump coronary artery bypass surgery: results from the CRYSSA (prevention of Coronary arteRY bypaSS occlusion After off-pump procedures) randomised study","volume":"98","author":"Mannacio","year":"2012","journal-title":"Heart"},{"key":"R40-10-20210204","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1161\/CIRCULATIONAHA.113.008227","article-title":"Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial","volume":"130","author":"Une","year":"2014","journal-title":"Circulation"},{"key":"R41-10-20210204","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/jocs.12074","article-title":"Dual antiplatelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis","volume":"28","author":"Deo","year":"2013","journal-title":"J Card Surg"},{"key":"R42-10-20210204","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-5223(02)73472-7","article-title":"Is there a hypercoagulable state after off-pump coronary artery bypass surgery? What do we know and what can we do?","volume":"126","author":"Kurlansky","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R43-10-20210204","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jtcvs.2008.03.052","article-title":"Platelet activity and aspirin efficacy after off-pump compared with on-pump coronary artery bypass surgery: results from the prospective randomized trial PRAGUE 11-Coronary Artery Bypass and Reactivity of Thrombocytes (CABARET)","volume":"136","author":"Bednar","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R44-10-20210204","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"R45-10-20210204","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"R46-10-20210204","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jacc.2010.10.029","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial","volume":"57","author":"Held","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R47-10-20210204","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jacc.2012.03.030","article-title":"Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis","volume":"60","author":"Smith","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R48-10-20210204","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N Engl J Med"},{"key":"R49-10-20210204","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170\u200a000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"R50-10-20210204","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1161\/CIRCULATIONAHA.108.799445","article-title":"Impact of statin use on outcomes after coronary artery bypass graft surgery","volume":"118","author":"Kulik","year":"2008","journal-title":"Circulation"},{"key":"R51-10-20210204","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1056\/NEJM199701163360301","article-title":"The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"key":"R52-10-20210204","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jtcvs.2007.07.029","article-title":"Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery","volume":"134","author":"Thielmann","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R53-10-20210204","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90\u200a056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"R54-10-20210204","doi-asserted-by":"crossref","first-page":"86C","DOI":"10.1016\/S0002-9149(99)80476-7","article-title":"Lipid-lowering interventions in angiographic trials","volume":"76","author":"Rossouw","year":"1995","journal-title":"Am J Cardiol"},{"key":"R55-10-20210204","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"R56-10-20210204","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0735-1097(94)00341-M","article-title":"Relation of saphenous vein graft obstruction to serum cholesterol levels","volume":"25","author":"Daida","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"R57-10-20210204","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM198411223112101","article-title":"The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery","volume":"311","author":"Campeau","year":"1984","journal-title":"N Engl J Med"},{"key":"R58-10-20210204","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.athoracsur.2011.04.107","article-title":"Statin therapy and saphenous vein graft disease after coronary bypass surgery: analysis from the CASCADE randomized trial","volume":"92","author":"Kulik","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"R59-10-20210204","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/S0735-1097(00)00924-4","article-title":"HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins","volume":"36","author":"Yang","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R60-10-20210204","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0735-1097(99)00526-4","article-title":"Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury","volume":"35","author":"Indolfi","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R61-10-20210204","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1067\/mva.2002.122029","article-title":"Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration","volume":"36","author":"Porter","year":"2002","journal-title":"J Vasc Surg"},{"key":"R62-10-20210204","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/01.CIR.102.2.157","article-title":"Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG investigators","volume":"102","author":"Knatterud","year":"2000","journal-title":"Circulation"},{"key":"R63-10-20210204","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1010-7940(99)00034-2","article-title":"Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG","volume":"15","author":"Christenson","year":"1999","journal-title":"Eur J Cardiothorac Surg"},{"key":"R64-10-20210204","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0002-9149(01)01901-4","article-title":"Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease","volume":"88","author":"Christenson","year":"2001","journal-title":"Am J Cardiol"},{"key":"R65-10-20210204","doi-asserted-by":"crossref","first-page":"350","DOI":"10.5551\/jat.1925","article-title":"Long-term efficacy of pravastatin therapy in diabetic patients undergoing complete coronary revascularization","volume":"17","author":"Aihara","year":"2010","journal-title":"J Atheroscler Thromb"},{"key":"R66-10-20210204","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1755-5922.2009.00098.x","article-title":"Statins decrease adverse outcomes in coronary artery bypass for extensive coronary artery disease as well as left main coronary stenosis","volume":"28","author":"Gan","year":"2010","journal-title":"Cardiovasc Ther"},{"key":"R67-10-20210204","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/CIRCULATIONAHA.106.621763","article-title":"Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia after Cardiac Surgery) study","volume":"114","author":"Patti","year":"2006","journal-title":"Circulation"},{"key":"R68-10-20210204","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.amjcard.2010.01.341","article-title":"Association between statin use and the incidence of atrial fibrillation following hospitalization for coronary artery disease","volume":"105","author":"Kulik","year":"2010","journal-title":"Am J Cardiol"},{"key":"R69-10-20210204","doi-asserted-by":"crossref","first-page":"III39","DOI":"10.1161\/01.CIR.0000131517.20177.5a","article-title":"Beneficial cardiovascular pleiotropic effects of statins","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"key":"R70-10-20210204","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/01.CCM.0000201407.89977.EA","article-title":"Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery","volume":"34","author":"Chello","year":"2006","journal-title":"Crit Care Med"},{"key":"R71-10-20210204","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jacc.2006.04.070","article-title":"Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy","volume":"48","author":"Cannon","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R72-10-20210204","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N Engl J Med"},{"key":"R73-10-20210204","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.jacc.2007.12.054","article-title":"Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery","volume":"51","author":"Shah","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R74-10-20210204","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1053\/j.jvca.2009.02.008","article-title":"Perioperative statin therapy is associated with a significant and dose-dependent reduction of adverse cardiovascular outcomes after coronary artery bypass graft surgery","volume":"23","author":"Ouattara","year":"2009","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R75-10-20210204","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJMoa1507750","article-title":"Perioperative rosuvastatin in cardiac surgery","volume":"374","author":"Zheng","year":"2016","journal-title":"N Engl J Med"},{"key":"R76-10-20210204","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jama.2016.0548","article-title":"High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial","volume":"315","author":"Billings","year":"2016","journal-title":"JAMA"},{"key":"R77-10-20210204","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.athoracsur.2009.06.009","article-title":"Efficacy of aggressive lipid controlling therapy for preventing saphenous vein graft disease","volume":"88","author":"Hata","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"R78-10-20210204","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"R79-10-20210204","doi-asserted-by":"crossref","first-page":"I454","DOI":"10.1161\/CIRCULATIONAHA.105.001149","article-title":"Occurrence and risk factors for reintervention after coronary artery bypass grafting","volume":"114","author":"Sabik","year":"2006","journal-title":"Circulation"},{"key":"R80-10-20210204","doi-asserted-by":"crossref","first-page":"III90","DOI":"10.1161\/01.CIR.102.suppl_3.III-90","article-title":"HDL cholesterol level predicts survival in men after coronary artery bypass graft surgery: 20-year experience from the Cleveland clinic foundation","volume":"102","author":"Foody","year":"2000","journal-title":"Circulation"},{"key":"R81-10-20210204","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0735-1097(00)00973-6","article-title":"Prognostic factors for atherosclerosis progression in saphenous vein grafts: the postcoronary artery bypass graft (post-CABG) trial. Post-CABG trial investigators","volume":"36","author":"Domanski","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R82-10-20210204","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1161\/01.CIR.96.7.2137","article-title":"Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group","volume":"96","author":"Frick","year":"1997","journal-title":"Circulation"},{"key":"R83-10-20210204","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/1749-8090-8-172","article-title":"Does high-density lipoprotein influence the development of saphenous vein graft disease after coronary bypass surgery? Exploratory analysis from the CASCADE trial","volume":"8","author":"Jerzewski","year":"2013","journal-title":"J Cardiothorac Surg"},{"key":"R84-10-20210204","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0002-9149(00)00915-2","article-title":"Relation of serum triglyceride levels to survival after coronary artery bypass grafting","volume":"86","author":"Sprecher","year":"2000","journal-title":"Am J Cardiol"},{"key":"R85-10-20210204","first-page":"213","article-title":"The influence of serum triglycerides on the fate of aorto-coronary vein grafts","volume":"107","author":"Allard","year":"1972","journal-title":"Can Med Assoc J"},{"key":"R86-10-20210204","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/0002-9149(93)90182-C","article-title":"Clinical and angiographic prediction of myocardial infarction and recurrence of severe angina during a five-year follow-up after coronary artery bypass grafting","volume":"72","author":"Yli-Mayry","year":"1993","journal-title":"Am J Cardiol"},{"key":"R87-10-20210204","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0002-9149(97)00138-0","article-title":"Usefulness of hypertriglyceridemia in predicting myocardial infarction late after coronary artery bypass operation","volume":"79","author":"Voors","year":"1997","journal-title":"Am J Cardiol"},{"key":"R88-10-20210204","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/oxfordjournals.eurheartj.a060581","article-title":"Serum triglycerides and HDL cholesterol: major predictors of long-term survival after coronary surgery","volume":"15","author":"Linden","year":"1994","journal-title":"Eur Heart J"},{"key":"R89-10-20210204","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/14017430510035925","article-title":"Positive family history of coronary atherosclerosis and serum triglycerides may predict repeated coronary artery bypass surgery","volume":"39","author":"Mennander","year":"2005","journal-title":"Scand Cardiovasc J"},{"key":"R90-10-20210204","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-5223(19)36474-8","article-title":"Risk factors among patients undergoing repeat aorta-coronary bypass procedures","volume":"93","author":"Fox","year":"1987","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R91-10-20210204","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1185\/030079906X148508","article-title":"The effect of 24 months of combination statin and extended-release niacin on carotid intima-media thickness: ARBITER 3","volume":"22","author":"Taylor","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"R92-10-20210204","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa0907569","article-title":"Extended-release niacin or ezetimibe and carotid intima-media thickness","volume":"361","author":"Taylor","year":"2009","journal-title":"N Engl J Med"},{"key":"R93-10-20210204","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden","year":"2011","journal-title":"N Engl J Med"},{"key":"R94-10-20210204","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/eurheartj\/eht055","article-title":"2-THRIVE randomized placebo-controlled trial in 25673 high-risk patients of ER niacinlaropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment.","volume":"34","year":"2013","journal-title":"Eur Heart J"},{"key":"R95-10-20210204","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0140-6736(00)04209-4","article-title":"2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study.","volume":"357","year":"2001","journal-title":"Lancet"},{"key":"R96-10-20210204","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","article-title":"Effects of combination lipid therapy in type 2 diabetes mellitus","volume":"362","author":"Ginsberg","year":"2010","journal-title":"N Engl J Med"},{"key":"R97-10-20210204","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the field study): randomised controlled trial","volume":"366","author":"Keech","year":"2005","journal-title":"Lancet"},{"key":"R98-10-20210204","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"R99-10-20210204","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJMoa1500858","article-title":"Efficacy and safety of evolocumab in reducing lipids and cardiovascular events","volume":"372","author":"Sabatine","year":"2015","journal-title":"N Engl J Med"},{"key":"R100-10-20210204","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"Robinson","year":"2015","journal-title":"N Engl J Med"},{"key":"R101-10-20210204","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1093\/eurheartj\/ehn478","article-title":"Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry","volume":"29","author":"Mehta","year":"2008","journal-title":"Eur Heart J"},{"key":"R102-10-20210204","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jtcvs.2010.03.015","article-title":"Effect of beta-blocker use on outcomes after discharge in patients who underwent cardiac surgery","volume":"140","author":"Chan","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R103-10-20210204","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation study investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"R104-10-20210204","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00380-008-1114-1","article-title":"Prior coronary artery bypass graft surgery patients undergoing diagnostic coronary angiography have multiple uncontrolled coronary artery disease risk factors and high risk for cardiovascular events","volume":"24","author":"Boatman","year":"2009","journal-title":"Heart Vessels"},{"key":"R105-10-20210204","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIRCULATIONAHA.107.183885","article-title":"Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention","volume":"115","author":"Rosendorff","year":"2007","journal-title":"Circulation"},{"key":"R106-10-20210204","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"key":"R107-10-20210204","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"R108-10-20210204","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/HYP.0000000000000003","article-title":"An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention","volume":"63","author":"Go","year":"2014","journal-title":"Hypertension"},{"key":"R109-10-20210204","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1097\/01.hjh.0000194120.42722.ac","article-title":"The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients","volume":"23","author":"Liu","year":"2005","journal-title":"J Hypertens"},{"key":"R110-10-20210204","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT study group","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"R111-10-20210204","first-page":"703","article-title":"2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.","volume":"317","year":"1998","journal-title":"BMJ"},{"key":"R112-10-20210204","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"key":"R113-10-20210204","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jtcvs.2008.09.050","article-title":"Does preoperative atrial fibrillation increase the risk for mortality and morbidity after coronary artery bypass grafting?","volume":"137","author":"Ad","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R114-10-20210204","first-page":"CD003611","article-title":"Interventions for preventing postoperative atrial fibrillation in patients undergoing heart surgery","volume":"18","author":"Crystal","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"R115-10-20210204","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/anec.12004","article-title":"Prevention of post-coronary artery bypass grafting (CABG) atrial fibrillation: efficacy of prophylactic beta-blockers in the modern era: a meta-analysis of latest randomized controlled trials","volume":"18","author":"Khan","year":"2013","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"R116-10-20210204","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jacc.2007.04.060","article-title":"Cardiovascular protection using beta-blockers: a critical review of the evidence","volume":"50","author":"Bangalore","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R117-10-20210204","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/hrt.74.3.235","article-title":"Metoprolol treatment for two years after coronary bypass grafting: effects on exercise capacity and signs of myocardial ischaemia","volume":"74","author":"Sjoland","year":"1995","journal-title":"Br Heart J"},{"key":"R118-10-20210204","first-page":"1825","article-title":"The MACB study group.","volume":"16","year":"1995","journal-title":"Eur Heart J"},{"key":"R119-10-20210204","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/CIRCULATIONAHA.106.685073","article-title":"Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery","volume":"117","author":"Rouleau","year":"2008","journal-title":"Circulation"},{"key":"R120-10-20210204","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2165\/00003495-200262030-00003","article-title":"Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats","volume":"62","author":"Sica","year":"2002","journal-title":"Drugs"},{"key":"R121-10-20210204","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nrneph.2011.175","article-title":"Diuretic use in renal disease","volume":"8","author":"Sica","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R122-10-20210204","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1161\/CIRCULATIONAHA.106.180945","article-title":"Core components of cardiac rehabilitation\/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation","volume":"115","author":"Balady","year":"2007","journal-title":"Circulation"},{"key":"R123-10-20210204","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.amjcard.2005.03.046","article-title":"Relation of body mass index to fatal and nonfatal cardiovascular events after cardiac rehabilitation","volume":"96","author":"Sierra-Johnson","year":"2005","journal-title":"Am J Cardiol"},{"key":"R124-10-20210204","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0735-1097(00)00810-X","article-title":"Smoking cessation reduces mortality after coronary artery bypass surgery: a 20-year follow-up study","volume":"36","author":"van Domburg","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R125-10-20210204","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2143\/AC.64.5.2042694","article-title":"Reduction of cardiovascular event rate: different effects of cardiac rehabilitation in CABG and PCI patients","volume":"64","author":"Hansen","year":"2009","journal-title":"Acta Cardiol"},{"key":"R126-10-20210204","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/174182670100800306","article-title":"Cardiac rehabilitation after coronary artery bypass surgery: 10-year results on mortality, morbidity and readmissions to hospital","volume":"8","author":"Hedback","year":"2001","journal-title":"J Cardiovasc Risk"},{"key":"R127-10-20210204","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jacc.2009.01.078","article-title":"Cardiac rehabilitation and survival in older coronary patients","volume":"54","author":"Suaya","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R129-10-20210204","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.amjmed.2004.01.009","article-title":"Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials","volume":"116","author":"Taylor","year":"2004","journal-title":"Am J Med"},{"key":"R130-10-20210204","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1056\/NEJMra001529","article-title":"Cardiac rehabilitation and secondary prevention of coronary heart disease","volume":"345","author":"Ades","year":"2001","journal-title":"N Engl J Med"},{"key":"R131-10-20210204","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.CIR.0000151788.08740.5C","article-title":"Cardiac rehabilitation and secondary prevention of coronary heart disease: An American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in collaboration with the American Association of Cardiovascular and Pulmonary Rehabilitation","volume":"111","author":"Leon","year":"2005","journal-title":"Circulation"},{"key":"R132-10-20210204","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/0269215510376006","article-title":"Long-term effects of an expanded cardiac rehabilitation programme after myocardial infarction or coronary artery bypass surgery: a five-year follow-up of a randomized controlled study","volume":"25","author":"Pluss","year":"2011","journal-title":"Clin Rehabil"},{"key":"R133-10-20210204","first-page":"20","article-title":"A comprehensive cardiac rehabilitation program in post-CABG patients: a rationale and critical pathway","volume":"2","author":"Sethi","year":"2003","journal-title":"Crit Pathw Cardiol"},{"key":"R134-10-20210204","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/CIRCULATIONAHA.109.876383","article-title":"Relationship between cardiac rehabilitation and long-term risks of death and myocardial infarction among elderly Medicare beneficiaries","volume":"121","author":"Hammill","year":"2010","journal-title":"Circulation"},{"key":"R135-10-20210204","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1161\/CIR.0b013e3181f5185b","article-title":"AACVPR\/ACCF\/AHA 2010 update: performance measures on cardiac rehabilitation for referral to cardiac rehabilitation\/secondary prevention services: a report of the American Association of Cardiovascular and Pulmonary Rehabilitation and the American College of Cardiology Foundation\/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Clinical Performance Measures for Cardiac Rehabilitation)","volume":"122","author":"Thomas","year":"2010","journal-title":"Circulation"},{"key":"R136-10-20210204","first-page":"e652","article-title":"2011 ACCF\/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"124","author":"Hillis","year":"2011","journal-title":"Circulation"},{"key":"R137-10-20210204","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCULATIONAHA.111.066738","article-title":"Cardiac rehabilitation attendance and outcomes in coronary artery disease patients","volume":"126","author":"Martin","year":"2012","journal-title":"Circulation"},{"key":"R138-10-20210204","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ahj.2005.03.034","article-title":"Determinants of referral to cardiac rehabilitation programs in patients with coronary artery disease: a systematic review","volume":"151","author":"Cortes","year":"2006","journal-title":"Am Heart J"},{"key":"R139-10-20210204","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jacc.2009.02.080","article-title":"Predictors of cardiac rehabilitation referral in coronary artery disease patients: findings from the American Heart Association's Get With The Guidelines Program","volume":"54","author":"Brown","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R140-10-20210204","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1161\/CIRCULATIONAHA.107.701466","article-title":"Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery","volume":"116","author":"Suaya","year":"2007","journal-title":"Circulation"}],"container-title":["Current Opinion in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HCO.0000000000000331","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T14:12:11Z","timestamp":1657203131000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001573-201611000-00010"}},"subtitle":["a primer"],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":139,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/hco.0000000000000331","relation":{},"ISSN":["0268-4705"],"issn-type":[{"value":"0268-4705","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}